A multi-institutional meningioma MRI dataset for automated multi-sequence image segmentation

Dominic LaBella1, Omaditya Khanna2, Shan McBurney-Lin3

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.

Scientific Data
|May 15, 2024
PubMed

Insights

The BraTS Pre-operative Meningioma Dataset offers the largest collection of expert-annotated brain MRI scans for meningioma research. This resource aims to advance automated segmentation tools for improved patient care.

Area of Science:

  • Neuroimaging
  • Medical Image Analysis
  • Oncology

Background:

  • Meningiomas are common primary brain tumors causing significant morbidity and mortality.
  • Accurate diagnosis and monitoring rely heavily on multi-sequence brain MRI.
  • Current limitations exist in automated, objective, and quantitative tools for meningioma assessment.

Purpose of the Study:

  • To introduce the BraTS Pre-operative Meningioma Dataset, the largest multi-institutional expert-annotated dataset for meningioma research.
  • To facilitate the development of automated computational methods for meningioma segmentation.
  • To expedite the clinical integration of these automated tools for improved patient management.

Main Methods:

  • Compiled 1,141 multi-sequence MR images from six institutions.
  • Included four structural MRI sequences: T2, T2/FLAIR, pre-contrast T1, and post-contrast T1-weighted.
  • Provided expert-annotated segmentations for enhancing tumor, non-enhancing tumor, and surrounding non-enhancing T2/FLAIR hyperintensity, along with demographic data and CNS WHO grade.

Main Results:

  • Established the largest multi-institutional, expert-annotated, multi-sequence meningioma MRI dataset to date.
  • The dataset comprises 1,141 cases with detailed segmentation of tumor sub-compartments.
  • Includes demographic and clinical data to support comprehensive research.

Conclusions:

  • The BraTS Pre-operative Meningioma Dataset is a valuable resource for advancing automated meningioma analysis.
  • Its release aims to spur innovation in computational methods for segmentation.
  • Ultimately, the goal is to enhance the clinical care of patients with meningiomas.

Related Concept Videos